Thursday - May 16, 2024
Drug Manufacturer to Pay $2.25 Million to Settle Substances Act Allegations
April 10, 2024
BOSTON, Massachusetts, April 10 -- The U.S. Department of Justice Drug Enforcement Administration's New England Division issued the following news release:

NEWARK, N.J. - A pharmaceutical manufacturer agreed to pay $2.25 million to resolve allegations that it violated the Controlled Substances Act (CSA), DEA New Jersey Field Division Special Agent in Charge Cheryl Ortiz and U.S. Attorney Philip R. Sellinger announced today

The manufacturer, Novel Laboratories Inc. (Nov . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products